HUREL™ Micro Liver Metabolite ID Services
Carol Tomaszewski2023-04-06T07:24:52-05:00The HUREL Micro Liver platform continues to be the gold standard advanced cell culture model for use in liver [...]
Visikol to present at SELECTBIO’s December 2021 Conference
Carol Tomaszewski2021-11-05T15:34:56-05:00Visikol's Director of Drug Discovery, Peter Worthington Ph.D., to Present at SELECTBIO's 3D-Cell Culture, Organoids, and Organs-on-Chips Conference [...]
HUREL Models Assist in the Evaluation of Hepatoxicity
Carol Tomaszewski2021-10-25T09:07:40-05:00Many drug candidates fail during clinical trials and post-market withdrawal due to hepatoxicity or Drug Induced Liver Injury (DILI). [...]